Clincosm LogoSign in Get a demo

Osteoporosis, Postmenopausal

Showing 1 - 25 of 122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteoporosis, Postmenopausal Trial in Yantai (Denosumab)

Recruiting
  • Osteoporosis, Postmenopausal
  • Denosumab
  • Yantai, Shandong, China
    Shandong Boan Biotechnology Co., Ltd.
May 2, 2023

Cortical Bone Mechanics Technology Fracture Discrimination

Recruiting
  • Osteoporosis
  • +6 more
  • Cortical Bone Mechanics Technology
  • Gainesville, Florida
  • +4 more
Feb 7, 2023

Osteoporosis, Postmenopausal Trial in Port Saint Lucie (TVB-009, Prolia®)

Active, not recruiting
  • Osteoporosis, Postmenopausal
  • TVB-009
  • Prolia®
  • Port Saint Lucie, Florida
    Site 10101
Feb 1, 2023

Hypovitaminosis D, Osteoporosis, Postmenopausal, Menopause Trial in Mexico City (Cholecalciferol)

Completed
  • Hypovitaminosis D
  • +2 more
  • Mexico City, Gustavo A. Madero, Mexico
    Patricia Loranca-Moreno
Jan 24, 2023

Single or Repeat Zoledronate Versus Alendronate Following

Not yet recruiting
  • Osteoporosis, Postmenopausal
  • Zoledronate or Alendronate
  • Thessaloniki, Greece
    424 General Military Hospital
Jan 24, 2023

Osteoporosis, Postmenopausal Trial (early versus late biopsy)

Not yet recruiting
  • Osteoporosis, Postmenopausal
  • early versus late biopsy
  • (no location specified)
Jan 9, 2023

Osteoporosis, Postmenopausal Trial (Zoledronate, Placebo)

Not yet recruiting
  • Osteoporosis, Postmenopausal
  • (no location specified)
Dec 15, 2022

Hip Fractures, Osteoporosis, Postmenopausal Trial in Hong Kong (AGN1 Femoral Local Osteo-Enhancement Procedure Kit)

Completed
  • Hip Fractures
  • Osteoporosis, Postmenopausal
  • AGN1 Femoral Local Osteo-Enhancement Procedure Kit
  • Hong Kong, Hong Kong
    Queen Mary Hospital - Department of Orthopaedics and Traumatolog
Nov 28, 2022

Zoledronic Acid to Prevent Bone Loss Following Denosumab

Recruiting
  • Osteoporosis
  • +3 more
  • Zoledronic acid
  • Calgary, Alberta, Canada
    University of Calgary, McCaig Institute for Bone and Joint Healt
Nov 1, 2022

Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Cohort follow-up)

Recruiting
  • Osteoporosis, Postmenopausal
  • Cohort follow-up
  • Clermont-Ferrand, France
    CHU de Clermont-Ferrand
Oct 6, 2022

Osteoporosis, Postmenopausal Trial in Cairo (Calcium carbonate, Vitamin D3, laser acupuncture therapy)

Completed
  • Osteoporosis, Postmenopausal
  • Calcium carbonate
  • +2 more
  • Cairo, Egypt
    Kasr Alainy medical school
Sep 26, 2022

Primary Hyperparathyroidism, Osteoporosis, Postmenopausal Trial in Philadelphia

Active, not recruiting
  • Primary Hyperparathyroidism
  • Osteoporosis, Postmenopausal
    • Philadelphia, Pennsylvania
      Perelman Center for Advanced Medicine/ Hospital of the Universit
    Sep 22, 2022

    Osteoporosis, Osteoporosis, Postmenopausal Trial in Sant Cugat Del Vallès (Focal Vibration, Control Group)

    Not yet recruiting
    • Osteoporosis
    • Osteoporosis, Postmenopausal
    • Focal Vibration
    • Control Group
    • Sant Cugat Del Vallès, Barcelona, Spain
      Universitat Internacional de Catalunya
    Sep 13, 2022

    Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures Trial in Pittsburgh (denosumab, Placebo, Calcium and Vitamin

    Active, not recruiting
    • Osteoporosis, Postmenopausal
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Senior Communities
    Sep 7, 2022

    Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture Trial in Pittsburgh (Romosozumab, Placebo, Zoledronic acid)

    Recruiting
    • Osteoporosis
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Senior Communities
    Sep 7, 2022

    Osteoporosis, Postmenopausal Trial (AVT03 (denosumab))

    Recruiting
    • Osteoporosis, Postmenopausal
    • denosumab
    • Port Elizabeth, Gqeberha, South Africa
      PHOENIX Pharma(Pty)Ltd
    Sep 1, 2022

    Osteoporosis, Postmenopausal Trial in Jaipur (Denosumab, Denosumab-Ref)

    Recruiting
    • Osteoporosis, Postmenopausal
    • Jaipur, Rajasthan, India
      S. R. Kalla Memorial Gastro & General Hospital
    Aug 16, 2022

    Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

    Recruiting
    • Osteoporosis, Postmenopausal
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Jackson, Mississippi
      University of Mississippi Medical Center
    Aug 5, 2022

    Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)

    Not yet recruiting
    • Nonalcoholic Fatty Liver
    • Osteoporosis, Postmenopausal
    • (no location specified)
    Aug 6, 2022

    Osteoporosis, Postmenopausal Trial in Copenhagen, Køge (Maltodextrin, Calcium-carbonate, Calcium-enriched permeate)

    Active, not recruiting
    • Osteoporosis, Postmenopausal
    • Maltodextrin
    • +3 more
    • Copenhagen, Frederiksberg, Denmark
    • +1 more
    Jul 22, 2022

    Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Follow-up of patients with postmenopausal osteoporosis, with or without

    Recruiting
    • Osteoporosis, Postmenopausal
    • Follow-up of patients with postmenopausal osteoporosis, with or without fractures, requiring initiation of injectable bisphosphonate therapy as part of their usual care
    • Follow-up of patients with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of care with magnesium supplementation
    • Clermont-Ferrand, France
      CHU clermont-ferrand
    Jun 29, 2022

    Osteoporosis, Postmenopausal Trial in Ji'nan (EuBone ® capsule, )

    Not yet recruiting
    • Osteoporosis, Postmenopausal
    • EuBone ® capsule
    • placebo
    • Ji'nan, Shandong, China
      Shandong Provincial Qianfoshan Hospital
    May 30, 2022

    Osteoporosis, Postmenopausal Trial in Kennesaw (Quercetin (500 mg), Placebo (500 mg))

    Completed
    • Osteoporosis, Postmenopausal
    • Quercetin (500 mg)
    • Placebo (500 mg)
    • Kennesaw, Georgia
      Kennesaw State University
    May 7, 2022

    Osteoporosis, Postmenopausal, Type 2 Diabetes Trial in Seoul (Ibandronate Oral Tablet)

    Completed
    • Osteoporosis, Postmenopausal
    • Type 2 Diabetes
    • Ibandronate Oral Tablet
    • Seoul, Korea, Republic of
      Yeouido St.Mary's Hospital
    Mar 2, 2022

    Low Bone Mass, Osteoporosis, Postmenopausal Trial in Aurora (DHEA, Placebo, Exercise)

    Recruiting
    • Low Bone Mass
    • Osteoporosis, Postmenopausal
    • DHEA
    • +2 more
    • Aurora, Colorado
      University of Colorado Anschutz Medical Campus
    Feb 14, 2022